UCSD Spinout Antiva Biosciences Gets $22M
socalTECH
MARCH 29, 2017
The funding was led by Brace Pharma Capital, an also included NS Investment, Osage University Partners and Alexandria Venture Investments, plus Canaan Partners and Sofinnova Ventures. Vinzenz Ploerer of Brace Pharma has joined the company's board with the new funding. READ MORE>>.
Let's personalize your content